Identical twin brothers concordant for Langerhans’ cell histiocytosis and discordant for Epstein-Barr virus-associated haemophagocytic syndrome

被引:0
|
作者
Chun-Jung Chen
Tsyr-Yuh Ho
Jang-Jih Lu
Lai-Fa Sheu
Shih-Yi Lee
Chiung-Hsi Tien
Shin-Nan Cheng
机构
[1] National Defence Medical Centre,Department of Paediatrics, Tri
[2] Tri-Service General Hospital,Service General Hospital
[3] National Defence Medical Centre,Division of Clinical Pathology
[4] Tri-Service General Hospital,Department of Pathology
[5] National Defence Medical Centre,undefined
来源
关键词
Epstein-Barr virus; Haemophagocytic syndrome; Langerhans’ cell histiocytosis; Monozygotic twins;
D O I
暂无
中图分类号
学科分类号
摘要
We report on identical twin brothers, one of whom presented at 14 months of age with fever and clinical, laboratory and histological evidence of Epstein-Barr virus-associated haemophagocytic syndrome (EBV-AHS) and 4 months later with typical signs and symptoms of Langerhans’ cell histiocytosis (LCH). The other twin, without previous symptoms, also displayed at that time LCH associated with signs of recent EBV infection, but without symptoms of haemophagocytic syndrome. No mutation in the SH2D1A gene, as observed in X-linked lymphoproliferative disease, or in the perforin gene as observed in some cases of hereditary haemophagocytic syndrome, was found. Conclusion:the occurrence of haemophagocytic syndrome and Langerhans’ cell histiocytosis, although genetically based, can be triggered by environmental agents and viruses, in particular Epstein-Barr virus.
引用
收藏
页码:536 / 539
页数:3
相关论文
共 50 条
  • [21] FATAL EPSTEIN-BARR VIRUS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME
    KIKUTA, H
    SAKIYAMA, Y
    MATSUMOTO, S
    OHISHI, T
    NAKANO, T
    NAGASHIMA, T
    OKA, T
    HIRONAKA, T
    HIRAI, K
    BLOOD, 1993, 82 (11) : 3259 - 3264
  • [22] FATAL EPSTEIN-BARR VIRUS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME
    MROCZEK, EC
    WEISENBURGER, DD
    GRIERSON, HLL
    PURTILO, DT
    LABORATORY INVESTIGATION, 1986, 54 (01) : A45 - A45
  • [23] Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis
    Song, Yue
    Wang, Yini
    Wang, Zhao
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (05) : 717 - 723
  • [24] VIRUS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME DUE TO EPSTEIN-BARR VIRUS
    REISMAN, RP
    GRECO, MA
    HUMAN PATHOLOGY, 1984, 15 (03) : 290 - 293
  • [25] FATAL EPSTEIN-BARR VIRUS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME
    WILSON, ER
    MALLUH, A
    STAGNO, S
    CRIST, WM
    JOURNAL OF PEDIATRICS, 1981, 98 (02): : 260 - 262
  • [26] Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome
    Yoshioka, M
    Kikuta, H
    Ishiguro, N
    Endo, R
    Kobayashi, K
    JOURNAL OF MEDICAL VIROLOGY, 2003, 70 (03) : 410 - 419
  • [27] Sequential quantification of Epstein-Barr virus DNA in a case of Epstein-Barr virus-associated hemophagocytic syndrome
    Takahashi, T
    Oeda, E
    Sato, Y
    Tanizawa, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (03) : 290 - 291
  • [28] Epstein-Barr virus vectors for the treatment of Epstein-Barr virus-associated cancers
    Paillard, F
    HUMAN GENE THERAPY, 1998, 9 (08) : 1119 - 1120
  • [29] Epstein-Barr Virus-Associated Lymphomas
    Grywalska, Ewelina
    Rolinski, Jacek
    SEMINARS IN ONCOLOGY, 2015, 42 (02) : 291 - 303
  • [30] EPSTEIN-BARR VIRUS-ASSOCIATED MALIGNANCIES
    RICHTSMEIER, WJ
    WITTELS, EG
    MAZUR, EM
    CRC CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1987, 25 (02): : 105 - 136